Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up

Tue, 23rd Oct 2012 09:23

Aggreko: UBS cuts target from 2,750p to 2,550p, buy rating kept.ARM Holdings: Investec keeps buy rating and 800p target.Avacta: Panmure Gordon keeps buy rating and 1.75p target.AZ Electronic: Canaccord Genuity ups target from 360p to 376p, buy rating kept.Babcock: JPMorgan Cazenove ups target from 990p to 1,050p, overweight rating kept.Barclays: Exane BNP Paribas ups target from 330p to 340p, outperform rating kept; HSBC lifts target from 180p to 260p, neutral rating kept.BBA Aviation: Westhouse Securities downgrades to neutral.BP: Jefferies keeps hold rating and 450p target.BP Marsh & Partners: Panmure Gordon ups target from 125p to 130p, buy rating kept.British American Tobacco: Credit Suisse ups target from 3,400p to 3,430p, outperform rating kept.Bullabulling Gold: Westhouse Securities initiates with buy rating and 21p target..Burberry: Deutsche Bank keeps hold rating and 1,275p target.CRH: HSBC downgrades to neutral, target cut from 16p to 15p.Direct Line: Nomura initiates with reduce rating and 174p target.e-Therapeutics: Panmure Gordon keeps buy rating and 73p target.Experian: Jefferies keeps buy rating and 1,060p target; Seymour Pierce keeps reduce rating and 1,000p target.Genel Energy: HSBC downgrades to neutral, target upped from 816p to 830p.Hammerson: Jefferies raises target from 501p to 503p, hold rating kept.Inchcape: Panmure Gordon keeps hold rating and 430p target.Johnson Matthey: UBS cuts target from 2,378p to 2,300p, neutral rating kept.Laird: Investec keeps hold rating and 225p target.Mulberry: Barclays Capital cuts target from 1,600p to 1,250p, equal weight rating kept; Panmure Gordon slashes target from 2,000p to 1,100p, buy rating kept.N Brown: UBS ups target from 285p to 340p, buy rating kept.Premier Foods: Panmure Gordon keeps hold rating and 90p target; Investec puts buy rating and 100p target under review.Redrow: UBS downgrades to neutral, target lifted from 160p to 170p.SDL: Goldman Sachs cuts target from 915p to 820p, buy rating kept.Unilever: Oriel Securities downgrades to hold, target raised from 2,200p to 2,320p.Whitbread: Investec maintains sell rating and 1,650p target; Nomura maintains buy rating and 2,650p target; Panmure Gordon keeps hold rating and 1,994p target; Investec keeps sell rating and 1,650p target.BC
More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.